prof. MUDr. Jiří Litzman, CSc.
Department head, Department of Clinical Immunology and Allergology
Total number of publications: 226
2020
-
Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation
Journal of Clinical Immunology, year: 2020, volume: 40, edition: 3, DOI
-
European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management
Journal of Clinical Immunology, year: 2020, volume: 40, edition: 4, DOI
-
Neurological manifestation of immune system dysregulation resulting from CTLA-4 receptor mutation: a case report
MULTIPLE SCLEROSIS AND RELATED DISORDERS, year: 2020, volume: 45, edition: October 2020, DOI
-
Základy vyšetření v klinické imunologii
Year: 2020, type:
2019
-
Bacterial and fungal gut microbiota analysis in common variable immunodeficiency (CVID) disorders: paired case-control study
Year: 2019, type: Conference abstract
-
Bacterial but Not Fungal Gut Microbiota Alterations Are Associated With Common Variable Immunodeficiency (CVID) Phenotype
Frontiers in Immunology, year: 2019, volume: 10, edition: 1914, DOI
-
Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig (R)]) in the Treatment of Patients With Primary Immunodeficiencies
Frontiers in Immunology, year: 2019, volume: 10, edition: 40, DOI
-
Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, year: 2019, volume: 33, edition: UNSP 2058738419843381, DOI
-
CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID
Frontiers in Immunology, year: 2019, volume: 9, edition: 3135, DOI
-
Czech Hizentra Noninterventional Study With Rapid Push: Efficacy, Safety, Tolerability, and Convenience of Therapy With 20% Subcutaneous Immunoglobulin
Clinical Therapeutics, year: 2019, volume: 41, edition: 11, DOI